Veli-Matti Kosma

researcher, MD, PhD, professor, head of University of Eastern Finland School of Medicine

Born 2000-01-01

Veli-Matti Kosma is …
instance of (P31):
humanQ5

External links are
P213ISNI0000000140469784
P8980KANTO ID000048602
P244Library of Congress authority IDn2011184310
P496ORCID iD0000-0001-9794-9797
P214VIAF ID187275142
P10832WorldCat Entities IDE39PBJB8rbtwhCj74JD7fqMXVC

P27country of citizenshipFinlandQ33
P108employerUniversity of Eastern FinlandQ2093139
P734family nameKosmaQ37518857
KosmaQ37518857
KosmaQ37518857
P735given nameVeli-MattiQ56856923
Veli-MattiQ56856923
P106occupationresearcherQ1650915
P39position heldfull professorQ25339110
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q3601638611q13 is a susceptibility locus for hormone receptor positive breast cancer
Q3587156719p13.1 is a triple-negative-specific breast cancer susceptibility locus
Q338488952q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy
Q360214067q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium
Q371698739q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Q57250674A common coding variant in CASP8 is associated with breast cancer risk
Q35755874A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer
Q37192589A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
Q40283249A highly reproducible xenograft model for human ovarian carcinoma and application of MRI and ultrasound in longitudinal follow-up
Q37619303A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Q35870483A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
Q55043120A recurrent mutation in PALB2 in Finnish cancer families.
Q57305942A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
Q36748207Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review
Q45869391Adenovirus-mediated gene transfer into an experimental pancreatic tumour.
Q40656016Adenovirus‐mediated VEGF‐A gene transfer induces bone formationin vivo
Q39437211Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers
Q42107698Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer
Q45878085Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes
Q35681656Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis
Q39396206Antiangiogenic gene therapy with soluble VEGF-receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma
Q33713224Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice
Q72549891Apoptosis in breast cancer as related to histopathological characteristics and prognosis
Q71512317Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis
Q52597929Application of morphometry in tumor pathology.
Q34613673Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Q35218520Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
Q45979098Association analysis identifies 65 new breast cancer risk loci.
Q33828680Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival
Q53399411Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk.
Q37292963Association of ESR1 gene tagging SNPs with breast cancer risk
Q37268494Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Q35022847Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies
Q35532898Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Q57056093Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
Q74336375Azaserine-induced rat pancreas tumor model with transplantable cultured cells
Q37002955BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Q45871985Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods
Q46115524Body mass index and breast cancer survival: a Mendelian randomization analysis
Q73014289Bone recovery after a gluten-free diet: a 5-year follow-up study
Q68016552Breast cancer in young women: clinical, histological and morphometric prognostic factors
Q34327945Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
Q35940158Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Q37406868Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions
Q28183827CD44 expression indicates favorable prognosis in epithelial ovarian cancer
Q36449203CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer
Q57278920CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population
Q40846389Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer
Q67943157Clinical, histological and quantitative prognostic factors in cutaneous malignant melanoma
Q43843779Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk
Q45867642Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice
Q39540928Combined respiratory effects of cold air with SO(2) or NO(2) in repeated 10-minute exposures of hyperventilating guinea pigs
Q73953743Combined respiratory effects of cold air with SO(2) or NO(2) in single 1-hour exposures of hyperventilating guinea pigs
Q35891162Common breast cancer susceptibility loci are associated with triple-negative breast cancer
Q35794653Common germline polymorphisms associated with breast cancer-specific survival
Q34379032Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q73093379Comparison of classic and quantitative prognostic factors in colorectal cancer
Q70595710Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer
Q34181322Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q74016824Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia
Q68147612DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer
Q44176489DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer
Q28345021Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogs
Q34497238Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer
Q35803454Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest
Q72374800Distribution and short-term effects of intratracheally instilled neutron-irradiated UO2 particles in the rat
Q39790048Dose and time dependency of inflammatory responses in the mouse lung to urban air coarse, fine, and ultrafine particles from six European cities
Q43245651Downregulated CD44 and hyaluronan expression in vulvar intraepithelial neoplasia and squamous cell carcinomas
Q37238492Downregulation of p21/WAF1 is related to advanced and dedifferentiated laryngeal squamous cell carcinoma
Q50857224Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma.
Q74178212Effects of 50 Hz magnetic fields on UV-induced skin tumourigenesis in ODC-transgenic and non-transgenic mice
Q73757441Effects of 50 Hz magnetic fields on cancer induced by ionizing radiation in mice
Q39650770Effects of mobile phone radiation on UV-induced skin tumourigenesis in ornithine decarboxylase transgenic and non-transgenic mice.
Q54357747Effects of mobile phone radiation on X-ray-induced tumorigenesis in mice.
Q71171651Effects of simulated nuclear fuel particles on the histopathology and CYP enzymes in the rat lung and liver
Q45228871Elevated expression of hyaluronan and its CD44 receptor in the duodenal mucosa of coeliac patients
Q44220730Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors.
Q57250672Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk
Q42520511Ethylenethiourea and nabam induced alterations of function and morphology of thyroid gland in rats
Q73322203Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer. Finbladder Group
Q36720821Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q37342144Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Q38462298Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer
Q73336751Expression and prognostic value of alpha-, beta-, and gamma-catenins indifferentiated thyroid carcinoma
Q31789296Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer
Q53435467Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
Q42467180Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up
Q47345941Expression of HER2 and its association with AP-2 in breast cancer
Q73676491Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation
Q24297789Expression of betaglycan, an inhibin coreceptor, in normal human ovaries and ovarian sex cord-stromal tumors and its regulation in cultured human granulosa-luteal cells
Q71986141Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival
Q41975154Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival
Q44836609Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer
Q73841951Expression of hyaluronan in benign and malignant breast lesions
Q42457364Expression of hyaluronan in normal and dysplastic bronchial epithelium and in squamous cell carcinoma of the lung
Q33444259Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content
Q73364825Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis
Q34372081Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis
Q43996199Expression of p53 and p21 Ki-ras proteins in rat thyroid gland tumors induced by 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX).
Q70872949Expression of p53 protein has no independent prognostic value in breast cancer
Q72326571Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival
Q35399244Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation
Q36620965Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer
Q64929653Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.
Q53514045Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.
Q37394076FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome
Q42683589FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
Q42153252Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma
Q37236216Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).
Q36111237Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus
Q35524465Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Q61230414Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
Q92480972Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Q39844032Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
Q36248936Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk
Q34903062Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Q37367871Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Q34979715Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
Q57278925Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas
Q36124728Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Q36742577Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Q57305903Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility
Q54395614GASC1 expression in lung carcinoma is associated with smoking and prognosis of squamous cell carcinoma.
Q54617426Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease.
Q33589487Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes
Q33197201Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p.
Q37739048Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
Q35925620Genetic predisposition to ductal carcinoma in situ of the breast
Q35151684Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q34378972Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Q30000080Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
Q28388497Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q35996692Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Q24622610Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Q29417100Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
Q24645441Genome-wide association study identifies novel breast cancer susceptibility loci
Q64040390Genome-wide association study of germline variants and breast cancer-specific mortality
Q56903217Genomewide search and association studies in a Finnish celiac disease population: Identification of a novel locus and replication of the HLA and CTLA4 loci
Q43575811Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.
Q43871398Gonadotrophins inhibit the expression of insulin-like growth factor binding protein-related protein-2 mRNA in cultured human granulosa-luteal cells
Q36276540Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Q33330850Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
Q36547888Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers
Q51450789High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.
Q73383737High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer
Q44022340High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer
Q43582728High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer
Q35770507High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma
Q44565959Histological assessment of the prognostic factors in female breast cancer
Q34475807Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer
Q53811641Histopathological and morphometrical analysis applied to skin changes in NMRI mice induced by dithranol (anthranil) and its acyl analogs.
Q58244337Hormone Receptors as Prognostic Factors in Female: Breast Cancer
Q67819119Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma
Q39458163Human carotid arteries: correlation of intravascular US with angiographic and histopathologic findings
Q43856146Hyaluronan expression in differentiated thyroid carcinoma
Q36617504Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate
Q37158644Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan
Q35745456Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival
Q33704516Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
Q44168152Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival
Q42435892Hyaluronan, CD44 and versican in epidermal keratinocyte tumours
Q54569063Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma.
Q41931639Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer
Q73081830Hypothyroidism after radiotherapy for laryngeal cancer
Q35102646Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Q36859142Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Q34038964Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions
Q36014067Identification of novel genetic markers of breast cancer survival
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q44430058Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer
Q38458827Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer
Q30710606Inducible nitric oxide synthase expression in pharyngeal squamous cell carcinoma: relation to p53 expression, clinicopathological data, and survival
Q34202917Inflammatory potential of the spores of Penicillium spinulosum isolated from indoor air of a moisture-damaged building in mouse lungs
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q34898735Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
Q74593307Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma
Q73639317Is the subsite distribution of laryngeal cancer related to smoking habits?
Q47190168Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium
Q36375268KDM4A, KDM4B and KDM4C in non-small cell lung cancer
Q41581759KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes
Q57191573Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair
Q28267893Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair
Q29416989Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Q71820008Life‐long over‐expression of ornithine decarboxylase (ODC) gene in transgenic mice does not lead to generally enhanced tumorigenesis or neuronal degeneration
Q74495363Lipid peroxidation products and antioxidant capacity in portal venous and systemic arterial plasma during gradual intestinal ischemia and reperfusion in pigs
Q73263784Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables
Q35642678Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival
Q35119701Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Q68044525Lymphocyte infiltrates as a prognostic variable in female breast cancer
Q58769239Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls
Q47736522Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella
Q72797532Mast cells in breast cancer
Q51015419Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer.
Q36619164Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women
Q73480107Merkel cell carcinoma of the auricle
Q34497352MicroRNA related polymorphisms and breast cancer risk
Q34123806Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls
Q41923291Mitotic indexes as prognostic predictors in female breast cancer
Q36292687Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma
Q42706074MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen
Q31147360Morphometric analysis of the small intestine in wild type mice C57BL/6L -- a developmental study.
Q36897003Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Q24811182Mycobacterium terrae isolated from indoor air of a moisture-damaged building induces sustained biphasic inflammatory response in mouse lungs
Q46567991NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer
Q45194389NAT2 slow acetylator genotype as an important modifier of breast cancer risk
Q37356243Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Q30374367No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Q37079859No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
Q34594981No observed local immunological response at cell level after five years of oats in adult coeliac disease
Q73216234Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma
Q74690696Nuclear and cytoplasmic p53 expression in pharyngeal squamous cell carcinoma: prognostic implications
Q35397312Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma
Q33495389Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression
Q42601584Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer
Q73158896Nuclear morphometry as a predictor of disease outcome in gastric cancer
Q69015163Observer variation in interactive computerized morphometry
Q44257284Obstetric prognosis after placental abruption
Q55032863Osteoporosis in adult patients with celiac disease.
Q34351474Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer
Q28584533PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Q47143943PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.
Q34289136Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche
Q27851443Penetrance analysis of the PALB2 c.1592delT founder mutation
Q36873786Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q57278958Polymorphic catechol-O-methyltransferase gene and breast cancer risk
Q36066735Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
Q44021268Potential of nuclear morphometry and volume-corrected mitotic index in grading transitional cell carcinoma of the urinary bladder.
Q44569490Preclinical safety, toxicology, and biodistribution study of adenoviral gene therapy with sVEGFR-2 and sVEGFR-3 combined with chemotherapy for ovarian cancer
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q67881188Prediction of outcome after first recurrence of breast cancer
Q70532790Predictive value of a morphometric prognostic index in female breast cancer
Q43968046Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer
Q57278972Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer
Q41261406Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI.
Q44930415Primary malignant schwannoma of the small bowel
Q36180689Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer
Q68108346Prognostic factors after 5 years follow-up in female breast cancer
Q67839931Prognostic factors in axillary lymph node-negative (pN−) breast carcinomas
Q36135969Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration
Q45828735Prognostic factors in gastric carcinoma - reply.
Q68071260Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer
Q35769582Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer
Q73236066Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy
Q71985955Prognostic value of cathepsin-D expression in female breast cancer
Q32159926Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma
Q73828602Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
Q47756115Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q40077918Pulmonary inflammation and tissue damage in the mouse lung after exposure to PM samples from biomass heating appliances of old and modern technologies
Q64361230Quantitation of staining for amyloid in histological sections: sources of variation, correlation analysis, and interstain reproducibility
Q114182625Rare germline copy number variants (CNVs) and breast cancer risk
Q57278973Receiver-operating characteristic (ROC) curve analysis of cathepsin D and pS2 in breast disease; results from a prospective study
Q73131535Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma
Q73028633Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma
Q37229463Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma
Q35398680Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer
Q38449110Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma
Q51803936Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
Q35829460Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma
Q35155449Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Q28301674Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population
Q68954346Reproducibility and variation of morphometric analysis of carcinoembryonic antigen staining in histopathology. The influence of standardized microscopic fields
Q53896112Reproducibility of morphometric measurements of amyloid after various staining methods.
Q45951126Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
Q37300024Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Q50849173SIP1 predicts progression and poor prognosis in pharyngeal squamous cell carcinoma.
Q36545934SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival
Q42934843ST14 gene variant and decreased matriptase protein expression predict poor breast cancer survival
Q34307873SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?
Q69243410Sampling in diagnostic morphometry: the influence of variation sources
Q72159127Sapphire probe versus bare fiber in interstitial laser hyperthermia (ILH). An experimental study with Wistar rats
Q34266010Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer
Q57278977Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer
Q45174545Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer
Q44231576Spores of Aspergillus versicolor isolated from indoor air of a moisture-damaged building provoke acute inflammation in mouse lungs
Q52891526Standardized mitotic counts in breast cancer. Evaluation of the method.
Q30580197Stent placement versus percutaneous transluminal angioplasty of human carotid arteries in cadavers in situ: distal embolization and findings at intravascular US, MR imaging and histopathologic analysis
Q40731645Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.
Q44100252Supraglottic and glottic carcinomas. clinically and biologically distinct entities?
Q33566957TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer
Q50218828Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.
Q49817640The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
Q36917100The UGT1A6_19_GG genotype is a breast cancer risk factor
Q68170597The changing importance of prognostic factors in breast cancer during long-term follow-up
Q71740242The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer
Q59344240The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae
Q30884328The morphological changes in rat bladder after photodynamic therapy with 5-aminolaevulinic acid-induced protoporphyrin IX.
Q74128967The prognostic value of inducible nitric oxide synthase in local prostate cancer
Q38964801The reciprocal association between mammographic breast density, hyaluronan synthesis and patient outcome
Q36142060The role of genetic breast cancer susceptibility variants as prognostic factors
Q45278364The significance of nuclear morphometric variables as prognostic predictors in breast cancer
Q68751013Toxicity of richterite in hemolysis test and macrophage cultures
Q43850081Transcription factor snail1 expression and poor survival in pharyngeal squamous cell carcinoma
Q33821467Transcription factors zeb1, twist and snai1 in breast carcinoma
Q74093456Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer
Q47419710Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer
Q33990838Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression
Q38428338Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact
Q33910850Type II transmembrane serine protease gene variants associate with breast cancer
Q33932788Verrucous carcinoma of the anus containing human papillomavirus type 16 DNA detected by in situ hybridisation: a case report
Q44594532Versican in epithelial ovarian cancer: Relation to hyaluronan, clinicopathologic factors and prognosis
Q45265824Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis
Q28258209Very low mammographic breast density predicts poorer outcome in patients with invasive breast cancer
Q50592574Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function.
Q44843638Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk
Q25257811XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study
Q57278886XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer
Q70186783[Cardiac amyloidosis]
Q74500692[Primary malignant melanoma of the larynx]
Q51021180alpha-, beta- and chi-catenin expression in human pancreatic cancer.
Q36618938p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival
Q36619342p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer
Q36641213p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis
Q33918416p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women
Q73690528p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma
Q44118215p53-independent apoptosis in UV-irradiated mouse skin: possible inhibition by 50 Hz magnetic fields
Q37414133rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk
Q28534781Γ-secretase components as predictors of breast cancer outcome

Search more.